Establishment Labs Holdings Inc. (ESTA)
NASDAQ: ESTA · Real-Time Price · USD
69.06
-1.35 (-1.92%)
At close: Mar 9, 2026, 4:00 PM EDT
69.06
0.00 (0.00%)
After-hours: Mar 9, 2026, 4:10 PM EDT
Company Description
Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgeries.
The company offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides breast tissue expanders.
The company sells products to physicians, hospitals, and clinics through distributors and its direct sales force in Europe, the Middle East, Africa, Latin America, the Asia-Pacific, and North America.
Establishment Labs Holdings Inc. was incorporated in 2004 and is headquartered in Alajuela, Costa Rica.
Establishment Labs Holdings Inc.
| Country | Costa Rica |
| Founded | 2004 |
| IPO Date | Jul 19, 2018 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 1,023 |
| CEO | Fillipo Caldini |
Contact Details
Address: Building B23 and B25, Coyol Free Zone Alajuela Costa Rica | |
| Phone | 506 2434 2400 |
| Website | establishmentlabs.com |
Stock Details
| Ticker Symbol | ESTA |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001688757 |
| CUSIP Number | G31249108 |
| ISIN Number | VGG312491084 |
| Employer ID | 98-1436377 |
| SIC Code | 3842 |
Key Executives
| Name | Position |
|---|---|
| Fillipo Peter Caldini | Chief Executive Officer and Director |
| Juan Jose Chacon Quiros | Founder and Executive Director |
| Rajbir Singh Denhoy | Chief Financial Officer |
| S. Ross Mansbach | General Counsel, Chief Compliance Officer and Chief Human Resources Officer |
| Roberto de Mezerville | Chief Technology Officer |
| Ivan Bilic | Senior Vice President of Commercial Operations - OUS |
| Jeff Ehrhardt | Senior Vice President and GM of North America |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Feb 27, 2026 | S-8 | Securities to be offered to employees in employee benefit plans |
| Feb 27, 2026 | 10-K | Annual Report |
| Feb 24, 2026 | 8-K | Current Report |
| Feb 19, 2026 | SCHEDULE 13G/A | Filing |
| Feb 13, 2026 | SCHEDULE 13G/A | Filing |
| Feb 13, 2026 | SCHEDULE 13G/A | Filing |
| Jan 14, 2026 | 8-K | Current Report |
| Jan 12, 2026 | 8-K | Current Report |
| Nov 14, 2025 | SCHEDULE 13G/A | Filing |
| Nov 7, 2025 | 10-Q | Quarterly Report |